| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.18 | 0.2 |